Chemours
439 hedge funds and large institutions have $2.4B invested in Chemours in 2019 Q4 according to their latest regulatory filings, with 91 funds opening new positions, 119 increasing their positions, 125 reducing their positions, and 59 closing their positions.
54% more first-time investments, than exits
New positions opened: 91 | Existing positions closed: 59
40% more funds holding in top 10
Funds holding in top 10: 5 → 7 (+2)
23% more capital invested
Capital invested by funds: $1.96B → $2.4B (+$442M)
5% more funds holding
Funds holding: 418 → 439 (+21)
0.92% more ownership
Funds ownership: 80.3% → 81.22% (+0.92%)
5% less repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 125
65% less call options, than puts
Call options by funds: $46.5M | Put options by funds: $134M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$18.1M |
| 2 |
Two Sigma Investments
New York
|
+$15.9M |
| 3 |
Goldman Sachs
New York
|
+$13.2M |
| 4 |
APG Asset Management
Amsterdam,
Netherlands
|
+$12.4M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$11.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
-$48.4M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.9M |
| 3 |
JP Morgan Chase
New York
|
-$9.8M |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$9.74M |
| 5 |
SC
Selz Capital
New York
|
-$8.35M |
CC Hedge Fund Activity: Q4 2019 in Review
439 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q4 2019, worth a combined $2.4B — up 23% from $1.96B a quarter earlier.
Buyers outnumbered sellers: 91 funds opened new CC positions and 59 closed out — a net gain of 32 holders — while 119 added to existing stakes and 125 trimmed.
The largest buyer was Arrowstreet Capital, adding an estimated $18.1M. The largest seller was Norges Bank, cutting an estimated $48.4M.
- 439 institutional investors held Chemours (CC) as of Q4 2019, up from 418 in Q3 2019.
- Funds reported $2.4B of Chemours stock for Q4 2019, up 23% quarter-over-quarter.
- 91 funds opened new Chemours positions in Q4 2019 and 59 closed out, a net change of +32 holders.
- The largest Chemours buyer in Q4 2019 was Arrowstreet Capital, an estimated $18.1M added.
- The largest Chemours seller in Q4 2019 was Norges Bank, an estimated $48.4M sold.
Based on aggregated 13F filings for Q4 2019.